BENCHMARKS
Conditional gene expression using the Tet system is well established in eukaryotes (1) . The tetracyclinecontrolled transactivator (tTA) binds to P tet -1 in the absence of an effector and stimulates transcription of the successive target gene (2) . Effector tetracyclines abolish activation by tTA (Tet-Off). The reverse transactivator rtTA2 S -M2 contains a mutated tetR allele and activates P tet -1 only in the presence of an effector (Tet-On) (3) .
The most widely used effectors are tetracycline (tc) and doxycycline (dox) for tTA and dox for rtTA2 S -M2. Several other tc derivatives have been tested for their suitability as effectors of the Tet system in tobacco and human cell lines (4-7). Here we explore the induction characteristics of eight tc derivatives for tTA and rtTA2 S -M2 in HeLa cell lines. We chose the seven clinically licensed and commercially available antibiotics: tc, dox, demeclocycline (demeclo), minocycline (mino), chloro-tetracycline (Cl-tc), sancycline (san) and metacycline (meta), and additionally tigecycline (TGC), which belongs to the new group of glycylcyclines currently undergoing phase III clinical trials (www. clinicaltrials.gov). None of these derivatives, except for dox, have been tested with rtTA2 S -M2 before. A structural overview is provided in Figure 1 .
The HeLa cell line X1/5 contains tTA and a P tet -1 driven luciferase reporter construct stably integrated into the genome (2, 8) . Cells were seeded in 24-well plates and cultivated overnight before fresh Dulbecco's modified Eagle's medium (DMEM)/10% fetal calf serum (FCS) was added with the respective effector concentration. Cells were harvested 24 h after induction. Luciferase activities and protein concentrations were determined as described (9) . The expression response curves are shown in Figure 2, A We then examined activation of rtTA2 S -M2. The cell line HeLa X1/6 containing the P tet -1 luciferase reporter construct (2, 8) was stably transfected with PvuI linearized pWHE146 (10) to express rtTA2 S -M2. HR2 S M2L clones were selected with G418 and tested for inducible luciferase activity.
Expression response experiments were performed as described for X1/5. As shown in Figure 2C, BENCHMARKS and tc are not effectors for rtTA2 S -M2 in this cell line. Thus, not every effector for tTA necessarily activates rtTA2 S -M2, nor does an effector's potential to activate rtTA2 S -M2 reflect its effectiveness to reduce luciferase activity exerted by tTA. TGC, for example, is the weakest effector tested for tTA but an intermediate one for rtTA2 S -M2. Also, meta is weaker than dox for tTA, but not for rtTA2 S -M2. In general, rtTA2 S -M2 responds to 10-to 100-fold higher effector concentrations than tTA.
It has recently been published (7) that mino is an effector for rtTA (13) , weaker than dox but with better passage of the blood-brain barrier. As mino is a poor activator for rtTA2 S -M2 tested here, the more effective mino derivative TGC might be an even better alternative. We also explored activation by dox and tc in HeLa cells that were transiently cotransfected with plasmids encoding rtTA2 S -M2 and the P tet -1 driven luciferase reporter ( Figure 2D ). Transfection experiments were performed as described previously (9) . Transiently transfected rtTA2 S -M2 reacts to dox at lower concentrations than in the cell line HR2 S M2L (1 ng/mL versus 10 ng/ mL), and tc leads to reasonable activation at concentrations below 1000 ng/ mL. Transiently and stably transfected cells differ in the amount of transactivator and reporter construct. While stable cell lines harbor only one or maximally a few copies of the respective genes, transiently transfected cells contain many. The resulting high amounts of transactivator and reporter construct support low affinity interactions and, A and B) without effector (for tTA) or (C) with 1 μg/mL doxycycline (dox) (for rtTA2 S -M2) was standardized to 1000 ALU/μg protein, and all other values were corrected accordingly. (D) HeLa cells were transiently cotransfected with 10 ng pUHrT62-1 (3) encoding rtTA2 S -M2 and 100 ng pUHC13-3 (2) carrying the luciferase gene under P tet -1 control using Lipofectamine™ (Gibco Life Technologies, Gaithersburg, MD, USA). Cells were incubated with different effector concentrations. After 24 h, luciferase activity was determined as described. Values represent the means of triplicate samples with standard deviations given in ALU/μg total cell protein corrected for transfection efficiency (9) . The value obtained without effector was standardized to 1 corrected ALU/μg protein. All experiments were performed at least twice. TGC, tigecycline; demeclo, demeclocycline; mino, minocycline; Cl-tc, chlorotetracycline; san, sancycline; meta, metacycline. BENCHMARKS thus, affect Tet regulation (9, 10) .
In conclusion, activation of rtTA2 S -M2 by tc analogs can be compared by dose-response analysis of HR2 S M2L. However, the concentration needed to fully activate rtTA2 S -M2 depends on the intracellular amounts of the system's components, which may also vary between different clones of stable cell lines. Thus, this concentration has to be determined individually for each experimental setup.
Graded dox response is well known for Tet transregulators and can be exploited to achieve intermediate expression levels in cell culture (14) . However, because of the high sensitivity of the transactivator for dox, the concentration window is narrow. Small variations in the dox concentration result in large differences of transcriptional output (3) (Figure 2 ). The higher concentrations used with less efficient derivatives might buffer pharmacokinetic variations in transgenic animals, and intermediate expression levels could be more readily maintained.
So far, only dox has been used as an effector for rtTA2 S -M2. Its pharmacokinetic properties render it a very good effector for most applications (5). However, there are reports about toxicity (15) and slow-release kinetics (5, 6, 16) . Meta, an equally potent effector for rtTA2 S -M2, seems to be less toxic at high concentrations (17) . Its serum half-live is shorter than that of dox (18) , which should lead to a more rapid switch in gene expression (16) . The concentrations needed to fully induce rtTA2 S -M2 are obtained in all tissues tested (11) . As alternative effectors can readily be introduced to already existing systems, they can broaden the applicability and improve the performance of Tet transregulators.
